Point72 Hong Kong LTD Gilead Sciences, Inc. Call Options Transaction History

Point72 Hong Kong LTD

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $3.46 Million - $3.95 Million	58,100 Added 450.39%	71,000 $4.38 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $3.46 Million - $3.95 Million	58,100 Added 450.39%	71,000 $4.38 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $219,336 - $247,038	-3,800 Reduced 22.75%	12,900 $797,000
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $1.41 Million - $1.76 Million	-24,300 Reduced 59.27%	16,700 $993,000
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $1.85 Million - $2.02 Million	29,100 Added 244.54%	41,000 $2.82 Million
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $474,000 - $540,834	7,900 Added 197.5%	11,900 $769,000
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $226,600 - $258,200	4,000 New	4,000 $233,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.